about
A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystoniaThe Use of Deep Brain Stimulation in Tourette SyndromeThe glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of actionSubcortical evoked activity and motor enhancement in Parkinson's disease.Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosisSubthalamic nucleus activity optimizes maximal effort motor responses in Parkinson's disease.Exenatide and the treatment of patients with Parkinson's diseaseTracking Parkinson's: Study Design and Baseline Patient Data.Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohortMidline frontal cortex low-frequency activity drives subthalamic nucleus oscillations during conflictSubthalamic nucleus beta and gamma activity is modulated depending on the level of imagined grip force.Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: The Effect of Varying Stimulation ParametersEstimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.Skewering the subthalamic nucleus via a parietal approach.Clinical safety of brain magnetic resonance imaging with implanted deep brain stimulation hardware: large case series and review of the literature.Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review.Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging.Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome.Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease.Controlling Parkinson's disease with adaptive deep brain stimulation.Vascular parkinsonism: a review of the precision and frequency of the diagnosis.Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.The nature of tremor circuits in parkinsonian and essential tremorThe heterogeneity of idiopathic Parkinson's disease.In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease.Human subthalamic nucleus in movement error detection and its evaluation during visuomotor adaptation.Can Parkinson's disease be cured by stimulating neurogenesis?Subthalamic nucleus local field potential activity helps encode motor effort rather than force in parkinsonismCritical aspects of clinical trial design for novel cell and gene therapies.Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approachThe future challenges in Parkinson's disease.Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?Parkinson's disease dementia: a neural networks perspective.Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.Frequency specific activity in subthalamic nucleus correlates with hand bradykinesia in Parkinson's disease.Screening for VPS35 mutations in Parkinson's disease.Tremor Reduction by Deep Brain Stimulation Is Associated With Gamma Power Suppression in Parkinson's Disease.The International Deep Brain Stimulation Registry and Database for Gilles de la Tourette Syndrome: How Does It Work?Subthalamic nucleus deep brain stimulation induces impulsive action when patients with Parkinson's disease act under speed pressure
P50
Q24337555-487F63D5-627E-4A0C-8BCB-46B346EBA5F0Q26739914-8B44E4FD-8E54-4162-9BFA-BFE6C3A8507FQ26768527-7D24F941-C044-4592-9990-B907B54127B0Q27311339-331EA391-0EA7-4BB5-8DEE-E72782580AC4Q28534842-D05E4F20-406C-406C-AC79-17B0850A45CEQ30449865-81C85746-F503-43EC-B374-3985576FC4B8Q30540208-DF934359-4A7D-485B-B40A-E0716EA5CFCDQ31008758-92306351-EA31-404D-B6FE-4D3EE956AF5DQ31063778-B6FA1D57-2D8E-4601-B3D1-7E618BF66BFAQ33254837-D4707368-4E6C-44C2-AA85-E67DE6C9E9E6Q33639519-27484260-1ABB-45BA-9854-C37A95DE16C3Q33679081-0D077A45-4DCC-40C3-B9E8-1C523CBFA869Q33708929-A0B3A9A1-BFB0-499A-A572-911D6B06573DQ33793017-1021772B-E3B1-49D3-AFAF-1144D89AA1ADQ33811621-D25D83EC-CF00-41EC-BA19-79D3BCA2BF9AQ33992455-71F74168-483A-4E53-A724-3588ED74F70FQ34028498-3F3DA657-06E0-4710-92C7-0120828BA70FQ34102325-A7233BEF-A427-4D93-BD90-C79AF39253E6Q34234597-AEF33C0F-CF2D-4C16-8015-3A960B3E850AQ34385659-DC692F3C-C7E5-475F-9029-2C61E66BBC92Q34441898-532FE7F7-3244-4043-8D56-0D1F90FEE7EBQ34463977-78C817B4-5073-4267-B8F3-094B3BF52234Q34530719-4D2B7FD2-A7E0-469B-B57E-D1FE4B1060A7Q34555912-155DEB2C-93EF-45ED-BDBA-EA27BAAC082CQ34621293-06A91FC9-2DF4-4A6E-B1A0-DC58269FB0D7Q34633300-E203AAFD-EF0B-4DD6-A49F-06AB3BE2ED78Q34664279-A8F77E10-DB74-44E7-B4DE-E859D48FF502Q35183991-42D276AF-9780-44A6-827B-AFBA52536193Q35423507-C5DD847D-C825-4935-BEAC-EDE29C2688ABQ35664438-622FABE9-6691-4F46-A5FD-96245BAB4D62Q35671348-9FF8449D-74F8-4575-BC93-74CE678A1454Q35688444-698914DE-6DC5-4556-946B-B8CE12BB5438Q36143856-84AD617C-29AF-4487-8A40-1D29B411FCC2Q36186763-9F3B1CE3-B958-4DEC-AC4D-258F1FF30CFBQ36492310-183A8F67-8F14-4914-B91C-115E2A53C179Q36708375-84509EE8-51F4-473D-92F9-C86E87FDF8FCQ36775809-69924117-20AE-45B8-9A7D-4100568277B5Q36791120-29235D38-7B4C-4F50-90E3-6E5AC5AE5323Q36829638-226ABA24-108E-4851-A24B-D7A772100AB7Q36968673-48555D4C-258B-4E2E-9AC6-41F7E135CD3C
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-0752-1813
@en
name
Thomas Foltynie
@ast
Thomas Foltynie
@en
Thomas Foltynie
@es
Thomas Foltynie
@nl
type
label
Thomas Foltynie
@ast
Thomas Foltynie
@en
Thomas Foltynie
@es
Thomas Foltynie
@nl
altLabel
Foltynie T
@en
Tom Foltynie
@en
prefLabel
Thomas Foltynie
@ast
Thomas Foltynie
@en
Thomas Foltynie
@es
Thomas Foltynie
@nl
P214
P106
P214
P31
P4012
P496
0000-0003-0752-1813
P735
P7859
lccn-n2002134694